NRAS, NRAS proto-oncogene, GTPase, 4893

N. diseases: 611; N. variants: 17
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121434596
rs121434596
Entrez Id: 4893
Gene Symbol: NRAS
NRAS
CUI: C0027651
Disease:
Neoplasms
0.740 GeneticVariation BEFREE This unique trial will yield prospective information on the efficacy of cetuximab and whether this is further enhanced with chemotherapy in two distinct populations of patients with metastatic colorectal cancer: the "quadruple wild type", which may 'superselect' for tumours sensitive to EGFR-inhibition, and the rare KRAS G13D mutated tumours, which are also postulated to be sensitive to the drug. 27246726 2016
dbSNP: rs121434596
rs121434596
Entrez Id: 4893
Gene Symbol: NRAS
NRAS
CUI: C0027651
Disease:
Neoplasms
0.740 GeneticVariation BEFREE KRAS exon 2 mutation variants were associated with heterogeneous outcome compared with unmutated tumors with KRAS G12C and G13D (trend) being associated with rather poor survival. 27358379 2016
dbSNP: rs121434596
rs121434596
Entrez Id: 4893
Gene Symbol: NRAS
NRAS
CUI: C0027651
Disease:
Neoplasms
0.740 GeneticVariation BEFREE Mutations in primary tumors were identified in three regions; KARS (G13D) and APC (R876*) in P1-2, TP53 (A161S) in P1-3, and KRAS (G12D), PIK3CA (Q546R), and ERBB4 (T272A) in P1-4. 25623536 2015
dbSNP: rs121434596
rs121434596
Entrez Id: 4893
Gene Symbol: NRAS
NRAS
CUI: C0027651
Disease:
Neoplasms
0.740 GeneticVariation BEFREE Participating laboratories contributed information on KRAS mutation frequencies, including the G13D mutation type, as well as turnaround times for tumor block retrieval and testing. 24811330 2014
dbSNP: rs121434596
rs121434596
Entrez Id: 4893
Gene Symbol: NRAS
NRAS
CUI: C0027651
Disease:
Neoplasms
A 0.740 GeneticVariation CLINVAR Prospective enterprise-level molecular genotyping of a cohort of cancer patients. 25157968 2014